Commentary: assessment of amikacin for pediatric usage.
D000328:Adult; D000367:Age Factors; D000583:Amikacin / Q000378:metabolism / Q000627:therapeutic use* / Q000633:toxicity; D002648:Child; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D007612:Kanamycin / Q000031:analogs & derivatives*; D008826:Microbial Sensitivity Tests
D007612:Kanamycin; D000583:Amikacin